Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline to Prevent PTSD in Children
NCT00182078Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2002
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in post-traumatic stress disorder (PTSD) and major depressive disorder (MDD) comparing Sertraline with Placebo (2 arms). Primary endpoints: Diagnostic Interview Schedule for Children and Adolescents (DICA) - Parent at 24 weeks and Diagnostic Interview for Children and Adolescents (DICA) - Child at 24 weeks. Started Nov 2002; status: completed.
02
Drugs
sertraline
03
Conditions
post-traumatic stress disorder (PTSD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00182078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182078.